BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2021588)

  • 41. Programme choice for perimetry in neurological conditions (PoPiN): a systematic review of perimetry options and patterns of visual field loss.
    Hepworth LR; Rowe FJ
    BMC Ophthalmol; 2018 Sep; 18(1):241. PubMed ID: 30200926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reclaiming the Periphery: Automated Kinetic Perimetry for Measuring Peripheral Visual Fields in Patients With Glaucoma.
    Mönter VM; Crabb DP; Artes PH
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):868-875. PubMed ID: 28159974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative evaluation of oculokinetic perimetry and conventional perimetry in glaucoma.
    Alvarez E; Damato BE; Jay JL; McClure E
    Br J Ophthalmol; 1988 Apr; 72(4):258-62. PubMed ID: 3378021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Visual acuity and pattern of visual field loss at presentation in pituitary adenoma.
    Ogra S; Nichols AD; Stylli S; Kaye AH; Savino PJ; Danesh-Meyer HV
    J Clin Neurosci; 2014 May; 21(5):735-40. PubMed ID: 24656736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Basic and clinical aspects of modern perimetry].
    Otori T
    Nippon Ganka Gakkai Zasshi; 1998 Dec; 102(12):779-95. PubMed ID: 10025112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calibration of the Dicon Auto Perimeter 2000 compared with that of the Goldmann perimeter.
    Hart WM; Gordon MO
    Am J Ophthalmol; 1983 Dec; 96(6):744-50. PubMed ID: 6660263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pituitary tumor volume as a predictor of postoperative visual field recovery. Quantitative analysis using automated static perimetry and computed tomography morphometry.
    Hudson H; Rissell C; Gauderman WJ; Feldon SE
    J Clin Neuroophthalmol; 1991 Dec; 11(4):280-3. PubMed ID: 1838550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative Analysis of the Displacement of the Anterior Visual Pathway by Pituitary Lesions and the Associated Visual Field Loss.
    Boland MV; Lee IH; Zan E; Yousem DM; Miller NR
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(8):3576-80. PubMed ID: 27388050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of stimulus velocity in automated kinetic perimetry in young healthy participants.
    Hirasawa K; Shoji N; Okada A; Takano K; Tomioka S
    Vision Res; 2014 May; 98():83-8. PubMed ID: 24705075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pupillometer-based objective chromatic perimetry in normal eyes and patients with retinal photoreceptor dystrophies.
    Skaat A; Sher I; Kolker A; Elyasiv S; Rosenfeld E; Mhajna M; Melamed S; Belkin M; Rotenstreich Y
    Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2761-70. PubMed ID: 23482470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of somatostatin analogue on chiasmal dysfunction from pituitary macroadenomas.
    Warnet A; Timsit J; Chanson P; Guillausseau PJ; Zamfirescu F; Harris AG; Derome P; Cophignon J; Lubetzki J
    J Neurosurg; 1989 Nov; 71(5 Pt 1):687-90. PubMed ID: 2809722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical features associated with lesions other than pituitary adenoma in patients with an optic chiasmal syndrome.
    Mejico LJ; Miller NR; Dong LM
    Am J Ophthalmol; 2004 May; 137(5):908-13. PubMed ID: 15126157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Size threshold perimetry performs as well as conventional automated perimetry with stimulus sizes III, V, and VI for glaucomatous loss.
    Wall M; Doyle CK; Eden T; Zamba KD; Johnson CA
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3975-83. PubMed ID: 23633660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oculokinetic perimetry compared with Humphrey visual field analysis in the detection of glaucomatous visual field loss.
    Wishart PK
    Eye (Lond); 1993; 7 ( Pt 1)():113-21. PubMed ID: 8325400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Vigabatrin and visual field defects. A Danish material with evaluation of different screening methods].
    Riise P; Fledelius HC; Rogvi-Hansen Bà
    Ugeskr Laeger; 2003 Mar; 165(10):1034-8. PubMed ID: 12645411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Temporal summation of normal eyes and impaired regions of the visual field].
    Ogawa T; Furuno F; Seki A; Suzumura H; Yabuki K; Matsuo H
    Nippon Ganka Gakkai Zasshi; 1984 Sep; 88(9):1216-23. PubMed ID: 6524546
    [No Abstract]   [Full Text] [Related]  

  • 57. Scotomatous defects in the central visual field in pituitary adenomas.
    Sugita K; Sato O; Hirota T; Tsugane R; Kageyama N
    Neurochirurgia (Stuttg); 1975 Sep; 18(5):155-62. PubMed ID: 172816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimal rates of movement for kinetic perimetry.
    Johnson CA; Keltner JL
    Arch Ophthalmol; 1987 Jan; 105(1):73-5. PubMed ID: 3800748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison between Humphrey and frequency doubling perimetry for chiasmal visual field defects.
    Noval S; Contreras I; Rebolleda G; Muñoz-Negrete FJ; Ruiz de Zárate B
    Eur J Ophthalmol; 2005; 15(6):739-45. PubMed ID: 16329059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of Three Visual Field Tests in Children: Frequency Doubling Test, 24-2 and 30-2 SITA Perimetry.
    Han S; Baek SH; Kim US
    Semin Ophthalmol; 2017; 32(5):647-650. PubMed ID: 27404791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.